Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Immunol Methods ; 329(1-2): 81-91, 2008 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-17980384

RESUMO

To establish a characterized model of regulatory T cell (Treg) depletion in the cat we assessed the kinetics of depletion and rebound in peripheral and central lymphoid compartments after treatment with anti-CD25 antibody as determined by cell surface markers and FOXP3 mRNA expression. An 82% decrease in circulating CD4+CD25+ Tregs was observed by day 11 after treatment. CD4+CD25+ cells were also reduced in the thymus (69%), secondary lymphoid tissues (66%), and gut (67%). Although CD4+CD25+ cells rebound by day 35 post-treatment, FOXP3 levels remain depressed suggesting anti-CD25 antibody treatment has a sustainable diminutive effect on the Treg population. To determine whether CD25+ Treg depletion strategies also deplete activated CD25+ effector cells, cats were immunized with feline immunodeficiency virus (FIV) p24-GST recombinant protein, allowing them to develop a measurable memory response, prior to depletion with anti-CD25 antibody. Anti-FIV p24-GST effector cell activity in peripheral blood after depletion was sustained as determined by antigen-specific T cell proliferation and humoral responses against FIV p24-GST with an ELISA for antigen-specific feline IgG. Furthermore, development of an anti-mouse response in Treg-depleted cats was similar to control levels indicating the retained capacity to respond to a novel antigen. We conclude that despite alterations in CD25+ cell levels during depletion, the feline immune system remains functional. We demonstrate here a model for the study of disease pathogenesis in the context of reduced numbers of immunosuppressive CD4+CD25+ Tregs throughout the feline immune system.


Assuntos
Anticorpos Monoclonais , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Subunidade alfa de Receptor de Interleucina-2/metabolismo , Depleção Linfocítica/métodos , Linfócitos T Reguladores/imunologia , Animais , Formação de Anticorpos , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD8-Positivos/efeitos dos fármacos , Gatos , Proliferação de Células , Células Cultivadas , Fatores de Transcrição Forkhead/genética , Fatores de Transcrição Forkhead/metabolismo , Produtos do Gene gag/farmacologia , Imunoglobulina G/sangue , Memória Imunológica , Subunidade alfa de Receptor de Interleucina-2/imunologia , Ativação Linfocitária , RNA Mensageiro/metabolismo , Proteínas Recombinantes/farmacologia , Linfócitos T Reguladores/efeitos dos fármacos , Linfócitos T Reguladores/metabolismo , Fatores de Tempo
2.
FEMS Microbiol Lett ; 249(2): 227-31, 2005 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-16006076

RESUMO

A plasmid from Staphylococcus sciuri DD 4747 had three open reading frames: a replication gene, an N-acetylmuramyl-l-alanine amidase-like gene, and a gene similar to the lysostaphin endopeptidase resistance gene (epr/lif). The epr-like gene was introduced into S. aureus RN4220; the recombinant strain was more resistant to lysostaphin endopeptidase and its cell wall peptidoglycan contained more serines and fewer glycines than the parental strain with the shuttle vector alone. Based on both its function and its similarity to femAB, this gene is a member of the femABX-like immunity gene family. Furthermore, this is the first example of a femABX-like immunity gene that is not linked to the gene for the bacteriolytic enzyme against which it specifies immunity.


Assuntos
Plasmídeos , Staphylococcus/genética , Proteínas de Bactérias/genética , Sequência de Bases , Primers do DNA , DNA Bacteriano/genética , Resistência Microbiana a Medicamentos/genética , Endopeptidases/genética , Fases de Leitura Aberta , Mapeamento por Restrição
3.
FEMS Microbiol Lett ; 236(2): 205-11, 2004 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-15251198

RESUMO

Zoocin A is a streptococcolytic enzyme produced by Streptococcus equi subsp. zooepidemicus 4881 that has an unknown site of action on the peptidoglycans of susceptible organisms. Analysis of a mutant strain in which the genes for zoocin A and resistance to zoocin A were inactivated revealed that this strain was more susceptible to beta-lactam antibiotics than the parental organism. Purified zoocin A had weak beta-lactamase activity, bound radioactive penicillin covalently, and its streptococcolytic activity was inhibited by penicillin. Thus, zoocin A is a penicillin-binding protein and presumably is a D-alanyl endopeptidase.


Assuntos
Proteínas de Bactérias/metabolismo , Endopeptidases/metabolismo , Proteínas de Ligação às Penicilinas/metabolismo , Streptococcus equi/enzimologia , Antibacterianos/farmacologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/isolamento & purificação , DNA Bacteriano/química , DNA Bacteriano/isolamento & purificação , Endopeptidases/genética , Endopeptidases/isolamento & purificação , Deleção de Genes , Genes Bacterianos , Dados de Sequência Molecular , Mutação , Proteínas de Ligação às Penicilinas/genética , Análise de Sequência de DNA , Streptococcus equi/genética , Resistência beta-Lactâmica , beta-Lactamases/genética , beta-Lactamases/isolamento & purificação , beta-Lactamases/metabolismo , beta-Lactamas/metabolismo , beta-Lactamas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...